79362160 - MYLAB DISCOVERY SOLUTIONS

Information

  • Trademark
  • 79362160
  • Serial Number
    79362160
  • Registration Number
    7404130
  • Filing Date
    July 30, 2022
    4 years ago
  • Registration Date
    June 04, 2024
    2 years ago
  • Transaction Date
    December 13, 2024
    a year ago
  • Status Date
    June 04, 2024
    2 years ago
  • Published for Opposition Date
    March 19, 2024
    2 years ago
  • Location Date
    June 03, 2024
    2 years ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    KUNG, KAELIE
  • Attorney Docket Number
    LEX-TM7-US
    Attorney Name
    Christopher M. Turk
  • Owners
Mark Drawing Code
5
Mark Identification
MYLAB DISCOVERY SOLUTIONS
Case File Statements
  • GS0091: Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; food analysis apparatus for detection of DNA of adulterant in food; test tubes; DNA microarrays for laboratory use; chromatography equipment for laboratory purposes, namely chromatography columns for use in purification in the laboratory, gas chromatography apparatus for laboratory use; automatic chromatography apparatus for laboratory use; downloadable and recorded computer operating programs; downloadable and recorded software for detecting viral and bacterial infections, genetic sequences; downloadable mobile application software for detecting viral and bacterial infections, genetic sequences; DNA chips; gene amplifiers being laboratory apparatus; laboratory devices for detecting genetic sequences; chromatogram analyzers being apparatus for scientific and laboratory use; centrifuges for laboratory use; laboratory trays; laboratory pipettes; pipette tips for laboratory use; reagent bottles in the nature of laboratory equipment for laboratory use, sold empty
  • GS0051: Medical diagnostic reagents; drug testing kits containing primarily medical diagnostic reagents and assays for testing body fluids; specimen collection kits for use in virus testing consisting primarily of swabs for medical purposes; veterinary diagnostic reagents; pharmaceutical preparations for diagnostic purposes namely, for diagnosing viral and bacterial infections; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; vaccines; nucleic acid sequences for medical and veterinary purposes; medical diagnostic test strips for biological specimens for blood analysis, urine analysis, saliva analysis; diagnostic preparations for medical purposes for detecting genetic predispositions; diagnostic biomarkers being reagents for use in assessment of genomic analysis for medical use; diagnostic preparations for medical purposes for detecting mutation in prion genes; pregnancy test kits; nutritional supplements in tablet form; medicines for the treatment of biological diseases diagnosed using reagents in the form of tablets; therapeutic drugs and agents for the treatment of biological diseases diagnosed using reagents; pharmaceutical preparations for the treatment of biological diseases diagnosed using reagents
  • PM0001: MY LAB DISCOVERY SOLUTIONS
  • GS0011: Reagents for scientific or medical research use; reagents for scientific purposes for use in nucleic acid isolation and purification; diagnostic biomarkers being reagents for use in assessment of genomic analysis for scientific use; chromatography chemicals; purification preparations in the nature of chemicals for use in the purification of reagents for scientific and research use; chemical reagents for genetic identity testing for nonmedical purposes
  • GS0441: Medical diagnostic services being medical testing and medical analysis for diagnostic or treatment purposes; genetic testing of animals for diagnostic or treatment purposes; disease diagnosis services, namely, consulting services in the field of the diagnosis of disease; medical screening; medical analysis services for diagnostic purposes provided by medical laboratories; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; medical and health services relating to DNA, genetics and genetic testing, being generic testing for medical purposes; analysis and processing of blood plasma and stem cells being medical services; medical laboratory services for the analysis of samples taken from patients; providing cancer screening services
  • DS0000: "SOLUTIONS"
  • GS0101: Medical diagnostic apparatus for testing body fluids; testing apparatus for medical purposes for testing body fluids; apparatus for DNA and RNA testing for medical purposes; capillary tubes for samples for medical use; medical devices in the nature of apparatus for taking body fluid samples; analyzers for bacterial identification for medical purposes; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for the detection of abnormal prion protein; in vitro diagnostic testing apparatus incorporating chemical reagents for medical use; face masks for surgical use for anti bacterial protection; diagnostic testing apparatus for use in medical immunoassay procedures; blood sugar testing apparatus for medical diagnostic purposes
  • GS0421: Laboratory testing for microbial, chemical, biochemical, bacteriological and medical purposes; pharmaceutical testing ; Laboratory analysis in the field of molecular biology; product design and development of medical diagnostic apparatus; computer-aided diagnostic testing services for others for scientific research purposes; drug discovery services; biomedical research services; research and development services in the field of genomics; research laboratories , namely, providing laboratory research services in the field of bacteriology, virology, chemistry; DNA sequencing for medical research purposes; DNA screening for scientific research purposes; scientific research services relating to the isolation and cultivation of human tissues and cells for others; genetic engineering services, namely, scientific research in the field of genetics and genetic engineering; software as a service (SAAS) services featuring software for detecting viral and bacterial infections, genetic sequences; testing and analysis of blood plasma, red blood cells, white blood cells, blood platelets for scientific research purposes; scientific laboratory services in the field of genomics; preparation of biological samples for analysis of body fluids in research laboratories; scientific research services in the field of proteins, antibodies, microorganisms and cells; scientific research for medical purposes in the field of cancerous diseases; testing, inspection and research services in the fields of agriculture, livestock breeding and fisheries; pharmaceutical research
Case File Event Statements
  • 2/14/2023 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/9/2023 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/10/2023 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/17/2023 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/6/2023 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/7/2023 - 3 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/8/2023 - 3 years ago
    7 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 7/14/2023 - 3 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/14/2023 - 3 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/7/2023 - 3 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/10/2024 - 2 years ago
    11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 1/10/2024 - 2 years ago
    12 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/10/2024 - 2 years ago
    13 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/10/2024 - 2 years ago
    17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/10/2024 - 2 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/10/2024 - 2 years ago
    14 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/10/2024 - 2 years ago
    15 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 1/10/2024 - 2 years ago
    16 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/11/2024 - 2 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/12/2024 - 2 years ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/28/2024 - 2 years ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/28/2024 - 2 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/19/2024 - 2 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/19/2024 - 2 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/4/2024 - 2 years ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/4/2024 - 2 years ago
    26 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 11/16/2024 - a year ago
    29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/7/2024 - a year ago
    30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 12/9/2024 - a year ago
    34 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/9/2024 - a year ago
    32 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/9/2024 - a year ago
    31 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/9/2024 - a year ago
    35 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 12/9/2024 - a year ago
    33 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 11/16/2024 - a year ago
    28 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 9/4/2024 - 2 years ago
    27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR